Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 149

1.

Family Characteristics Associated with Likelihood of Varicella Vaccination.

Weinmann S, Mullooly JP, Drew L, Chun CS.

Perm J. 2016 Spring;20(2):54-8. doi: 10.7812/TPP/15-160. Epub 2016 Apr 15.

2.

Positive Predictive Value of ICD-9 Code for Herpes Zoster Among Children During the Varicella Vaccine Era.

Weinmann S, Vandermeer M, Roberts M, Mullooly J, Chun C.

Pediatr Infect Dis J. 2016 Apr;35(4):459-60. doi: 10.1097/INF.0000000000001040.

PMID:
26658628
3.

A Ten-Year Case-Control Study of Passive Smoke Exposure as a Risk Factor for Pertussis in Children.

Schmidt MA, Kurosky SK, Mullooly JP, Chun C, Weinmann S.

Perm J. 2015 Summer;19(3):59-63. doi: 10.7812/TPP/14-233.

4.

Passive cigarette smoke exposure and other risk factors for invasive pneumococcal disease in children: a case-control study.

Chun CS, Weinmann S, Riedlinger K, Mullooly JP.

Perm J. 2015 Winter;19(1):38-43. doi: 10.7812/TPP/14-010. Epub 2014 Nov 24.

5.

Wheezing lower respiratory disease and vaccination of premature infants.

Mullooly JP, Schuler R, Mesa J, Drew L, DeStefano F; VSD team.

Vaccine. 2011 Oct 13;29(44):7611-7. doi: 10.1016/j.vaccine.2011.08.022. Epub 2011 Aug 27.

PMID:
21875634
6.

Identifying optimal risk windows for self-controlled case series studies of vaccine safety.

Xu S, Zhang L, Nelson JC, Zeng C, Mullooly J, McClure D, Glanz J.

Stat Med. 2011 Mar 30;30(7):742-52. doi: 10.1002/sim.4125. Epub 2010 Nov 30.

PMID:
21394750
7.

Laboratory characteristics of suspected herpes zoster in vaccinated children.

Chun C, Weinmann S, Riedlinger K, Mullooly JP, Houston H, Schmid DS, Seward JF.

Pediatr Infect Dis J. 2011 Aug;30(8):719-21. doi: 10.1097/INF.0b013e3182137e35.

PMID:
21346684
8.

Frequency of medically attended events following rapid revaccination with trivalent inactivated influenza vaccine.

Schmidt MA, Crane B, Mullooly JP, Naleway AL.

Vaccine. 2010 Nov 16;28(49):7713-5. doi: 10.1016/j.vaccine.2010.09.043. Epub 2010 Sep 25.

PMID:
20875495
9.

Henoch-Schölein purpura and polysaccharide meningococcal vaccine.

Goodman MJ, Nordin JD, Belongia EA, Mullooly JP, Baggs J.

Pediatrics. 2010 Aug;126(2):e325-9. doi: 10.1542/peds.2009-3195. Epub 2010 Jul 12.

PMID:
20624811
10.

Multiple vaccinations and the risk of medically attended fever.

Lin ND, Kleinman K, Chan KA, Soumerai S, Mehta J, Mullooly JP, Shay DK, Kolczak M, Lieu TA; Vaccine Safety Datalink Team.

Vaccine. 2010 Jun 7;28(25):4169-74. doi: 10.1016/j.vaccine.2010.04.014. Epub 2010 Apr 18.

PMID:
20409495
11.

Influenza vaccination coverage among adult solid organ transplant recipients at three health maintenance organizations, 1995-2005.

Harris K, Baggs J, Davis RL, Black S, Jackson LA, Mullooly JP, Chapman LE.

Vaccine. 2009 Apr 14;27(17):2335-41. doi: 10.1016/j.vaccine.2009.02.026. Epub 2009 Feb 20.

PMID:
19428848
12.

Detecting possible vaccine adverse events in clinical notes of the electronic medical record.

Hazlehurst B, Naleway A, Mullooly J.

Vaccine. 2009 Mar 23;27(14):2077-83. doi: 10.1016/j.vaccine.2009.01.105. Epub 2009 Jan 31.

PMID:
19428833
13.

Medicaid coverage, methadone maintenance, and felony arrests: outcomes of opiate treatment in two states.

Deck D, Wiitala W, McFarland B, Campbell K, Mullooly J, Krupski A, McCarty D.

J Addict Dis. 2009;28(2):89-102. doi: 10.1080/10550880902772373.

14.

Identification and characteristics of vaccine refusers.

Wei F, Mullooly JP, Goodman M, McCarty MC, Hanson AM, Crane B, Nordin JD.

BMC Pediatr. 2009 Mar 5;9:18. doi: 10.1186/1471-2431-9-18.

15.

Predictive value of ICD-9-CM codes used in vaccine safety research.

Mullooly JP, Donahue JG, DeStefano F, Baggs J, Eriksen E; VSD Data Quality Working Group.

Methods Inf Med. 2008;47(4):328-35.

PMID:
18690366
16.

Comparison of epidemiologic methods for active surveillance of vaccine safety.

McClure DL, Glanz JM, Xu S, Hambidge SJ, Mullooly JP, Baggs J.

Vaccine. 2008 Jun 19;26(26):3341-5. doi: 10.1016/j.vaccine.2008.03.074. Epub 2008 May 6.

PMID:
18462849
17.

Laboratory diagnosis and characteristics of breakthrough varicella in children.

Weinmann S, Chun C, Mullooly JP, Riedlinger K, Houston H, Loparev VN, Schmid DS, Seward JF.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S132-8. doi: 10.1086/522148.

PMID:
18419386
18.

Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children.

France EK, Glanz J, Xu S, Hambidge S, Yamasaki K, Black SB, Marcy M, Mullooly JP, Jackson LA, Nordin J, Belongia EA, Hohman K, Chen RT, Davis R; Vaccine Safety Datalink Team.

Pediatrics. 2008 Mar;121(3):e687-92. doi: 10.1542/peds.2007-1578.

PMID:
18310189
19.

Effectiveness of influenza vaccine in the community-dwelling elderly.

Nichol KL, Nordin JD, Nelson DB, Mullooly JP, Hak E.

N Engl J Med. 2007 Oct 4;357(14):1373-81.

20.

Hepatitis B vaccine and risk of autoimmune thyroid disease: a Vaccine Safety Datalink study.

Yu O, Bohlke K, Hanson CA, Delaney K, Rees TG, Zavitkovsky A, Ray P, Mullooly J, Black SB, Benson P, Thompson WW, Davis RL, Jackson LA.

Pharmacoepidemiol Drug Saf. 2007 Jul;16(7):736-45.

PMID:
17192842
21.

Impact of maternal influenza vaccination during pregnancy on the incidence of acute respiratory illness visits among infants.

France EK, Smith-Ray R, McClure D, Hambidge S, Xu S, Yamasaki K, Shay D, Weintraub E, Fry AM, Black SB, Shinefield HR, Mullooly JP, Jackson LA.

Arch Pediatr Adolesc Med. 2006 Dec;160(12):1277-83.

PMID:
17146026
22.

Variation in hepatitis B immunization coverage rates associated with provider practices after the temporary suspension of the birth dose.

Lin ND, Kleinman K, Chan KA, Yu XJ, France EK, Wei F, Mullooly JP, Black S, Shay DK, Kolczak M, Lieu TA; Vaccine Safety Datalink Team.

BMC Pediatr. 2006 Nov 13;6:31.

23.

Compliance with the recommendations for 2 doses of trivalent inactivated influenza vaccine in children less than 9 years of age receiving influenza vaccine for the first time: a Vaccine Safety Datalink study.

Jackson LA, Neuzil KM, Baggs J, Davis RL, Black S, Yamasaki KM, Belongia E, Zangwill KM, Mullooly J, Nordin J, Marcy SM, DeStefano F.

Pediatrics. 2006 Nov;118(5):2032-7.

PMID:
17079576
24.

Influenza- and RSV-associated hospitalizations among adults.

Mullooly JP, Bridges CB, Thompson WW, Chen J, Weintraub E, Jackson LA, Black S, Shay DK; Vaccine Safety Datalink Adult Working Group.

Vaccine. 2007 Jan 15;25(5):846-55. Epub 2006 Sep 25.

PMID:
17074423
25.

Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old.

Hambidge SJ, Glanz JM, France EK, McClure D, Xu S, Yamasaki K, Jackson L, Mullooly JP, Zangwill KM, Marcy SM, Black SB, Lewis EM, Shinefield HR, Belongia E, Nordin J, Chen RT, Shay DK, Davis RL, DeStefano F; Vaccine Safety Datalink Team.

JAMA. 2006 Oct 25;296(16):1990-7.

PMID:
17062862
26.

Encephalopathy after whole-cell pertussis or measles vaccination: lack of evidence for a causal association in a retrospective case-control study.

Ray P, Hayward J, Michelson D, Lewis E, Schwalbe J, Black S, Shinefield H, Marcy M, Huff K, Ward J, Mullooly J, Chen R, Davis R; Vaccine Safety Datalink Group.

Pediatr Infect Dis J. 2006 Sep;25(9):768-73.

PMID:
16940831
27.

Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations.

Glanz JM, McClure DL, Xu S, Hambidge SJ, Lee M, Kolczak MS, Kleinman K, Mullooly JP, France EK.

J Clin Epidemiol. 2006 Aug;59(8):808-18. Epub 2006 Mar 15.

PMID:
16828674
28.

Vaccines, antibiotics, and atopy.

Mullooly JP, Schuler R, Barrett M, Maher JE.

Pharmacoepidemiol Drug Saf. 2007 Mar;16(3):275-88.

PMID:
16794993
29.

Detecting possible vaccination reactions in clinical notes.

Hazlehurst B, Mullooly J, Naleway A, Crane B.

AMIA Annu Symp Proc. 2005:306-10.

30.

Medical cost-offset following treatment referral for alcohol and other drug use disorders in a group model HMO.

Polen MR, Freeborn DK, Lynch FL, Mullooly JP, Dickinson DM.

J Behav Health Serv Res. 2006 Jul;33(3):335-46.

PMID:
16752110
31.

Delivering influenza vaccine to pregnant women.

Naleway AL, Smith WJ, Mullooly JP.

Epidemiol Rev. 2006;28:47-53. Epub 2006 May 26. Review.

PMID:
16731574
32.

Changing incidence and survival for heart failure in a well-defined older population, 1970-1974 and 1990-1994.

Barker WH, Mullooly JP, Getchell W.

Circulation. 2006 Feb 14;113(6):799-805. Epub 2006 Feb 6.

PMID:
16461823
33.

Trivalent inactivated influenza vaccine safety in children: assessing the contribution of telephone encounters.

Mullooly JP, Crane B, Chun C.

Vaccine. 2006 Mar 20;24(13):2256-63. Epub 2005 Dec 5.

PMID:
16375995
34.

Impact of the introduction of pneumococcal conjugate vaccine on immunization coverage among infants.

Lin ND, Kleinman K, Chan KA, Yu XJ, France EK, Xu S, Wei F, Mullooly J, Santoli J, Lieu TA; Vaccine Safety Datalink Group.

BMC Pediatr. 2005 Nov 28;5:43.

36.

Improving services for sex partners of chlamydia-infected patients in an HMO.

Mullooly JP, Valanis B, Maher JE, Vuckovic NA, Slepack J, Cooksey SG, Easter K, Stevens NH, Irwin K, Dixon J, Anderson LA.

Am J Manag Care. 2005 Oct;11(10):609-18.

37.

Assessment of the safety of a third dose of pneumococcal polysaccharide vaccine in the Vaccine Safety Datalink population.

Jackson LA, Nelson JC, Whitney CG, Neuzil KM, Benson P, Malais D, Baggs J, Mullooly J, Black S, Shay DK.

Vaccine. 2006 Jan 12;24(2):151-6. Epub 2005 Aug 10.

PMID:
16122845
38.

Incidence of herpes zoster, 1997-2002.

Mullooly JP, Riedlinger K, Chun C, Weinmann S, Houston H.

Epidemiol Infect. 2005 Apr;133(2):245-53.

39.

Teen reach: outcomes from a randomized, controlled trial of a tobacco reduction program for teens seen in primary medical care.

Hollis JF, Polen MR, Whitlock EP, Lichtenstein E, Mullooly JP, Velicer WF, Redding CA.

Pediatrics. 2005 Apr;115(4):981-9.

PMID:
15805374
40.

Compliance with national immunization guidelines for children younger than 2 years, 1996-1999.

Mell LK, Ogren DS, Davis RL, Mullooly JP, Black SB, Shinefield HR, Zangwill KM, Ward JI, Marcy SM, Chen RT; Centers for Disease Control and Prevention Vaccine Safety Datalink Project.

Pediatrics. 2005 Feb;115(2):461-7.

PMID:
15687456
41.

Secondary prevention of domestic violence in HMO primary care: evaluation of alternative implementation strategies.

Shye D, Feldman V, Hokanson CS, Mullooly JP.

Am J Manag Care. 2004 Oct;10(10):706-16.

42.

Safety of the trivalent inactivated influenza vaccine among children: a population-based study.

France EK, Glanz JM, Xu S, Davis RL, Black SB, Shinefield HR, Zangwill KM, Marcy SM, Mullooly JP, Jackson LA, Chen R.

Arch Pediatr Adolesc Med. 2004 Nov;158(11):1031-6.

PMID:
15520339
43.

Quality assessments of HMO diagnosis databases used to monitor childhood vaccine safety.

Mullooly J, Drew L, DeStefano F, Maher J, Bohlke K, Immanuel V, Black S, Lewis E, Ray P, Vadheim C, Lugg M, Chen R.

Methods Inf Med. 2004;43(2):163-70.

PMID:
15136866
44.

Evaluation of the impact of an HMO's varicella vaccination program on incidence of varicella.

Mullooly JP, Maher JE, Drew L, Schuler R, Hu W.

Vaccine. 2004 Mar 29;22(11-12):1480-5.

PMID:
15063572
45.

Infant vaccinations and childhood asthma among full-term infants.

Maher JE, Mullooly JP, Drew L, DeStefano F.

Pharmacoepidemiol Drug Saf. 2004 Jan;13(1):1-9.

PMID:
14971117
46.

Medically recorded allergies and the risk of childhood acute lymphoblastic leukaemia.

Spector L, Groves F, DeStefano F, Liff J, Klein M, Mullooly J, Black S, Shinefield H, Ward J, Marcy M; Vaccine Safety Datalink Project.

Eur J Cancer. 2004 Mar;40(4):579-84.

PMID:
14962726
47.
48.

Screening rarely screened women: time-to-service and 24-month outcomes of tailored interventions.

Valanis B, Whitlock EE, Mullooly J, Vogt T, Smith S, Chen C, Glasgow RE.

Prev Med. 2003 Nov;37(5):442-50.

PMID:
14572429
49.

Risk of anaphylaxis after vaccination of children and adolescents.

Bohlke K, Davis RL, Marcy SM, Braun MM, DeStefano F, Black SB, Mullooly JP, Thompson RS; Vaccine Safety Datalink Team.

Pediatrics. 2003 Oct;112(4):815-20.

PMID:
14523172
50.

A retrospective cohort study of the association of varicella vaccine failure with asthma, steroid use, age at vaccination, and measles-mumps-rubella vaccination.

Verstraeten T, Jumaan AO, Mullooly JP, Seward JF, Izurieta HS, DeStefano F, Black SB, Chen RT; Vaccine Safety Datalink Research Group.

Pediatrics. 2003 Aug;112(2):e98-103.

PMID:
12897314

Supplemental Content

Loading ...
Support Center